Press release
Chemotherapy Induced Nausea and Vomiting Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Domain | DelveInsight
Chemotherapy Induced Nausea and Vomiting Pipeline
In the Chemotherapy Induced Nausea and Vomiting pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Chemotherapy Induced Nausea and Vomiting NDA approvals (if any), and product development activities comprising the technology, Chemotherapy Induced Nausea and Vomiting collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
To explore more information on the latest breakthroughs in the Chemotherapy Induced Nausea and Vomiting Pipeline treatment landscape of the report, click here @ Chemotherapy Induced Nausea and Vomiting Pipeline Outlook- https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Chemotherapy Induced Nausea and Vomiting Pipeline Report
• DelveInsight's Chemotherapy Induced Nausea and Vomiting Pipeline analysis depicts a robust space with 15+ active players working to develop 14+ pipeline treatment therapies.
• The leading companies working in the Chemotherapy Induced Nausea and Vomiting Market include Acacia Pharma, Camurus, LP Pharmaceuticals, Skye Bioscience, TALLC Corporation, Starton Therapeutics, and others.
• Promising Chemotherapy Induced Nausea and Vomiting Pipeline Therapies in the various stages of development include SP-01 (Granisetron Transdermal Delivery System), Granisetron Hydrochloride Tablet, Pro-netupitant/Palonosetron, Netupitant/Palonosetron, Dexamethasone, Aprepitant, I.V. palonosetron, and others.
• On January 2023, Xiamen LP Pharmaceutical Co., Ltd announced a study of phase 3 clinical trials for Palonosetron HCl Buccal Film 0.5 mg. The phase 3 study is to compare the efficacy and safety of palonosetron, a long-acting 5-HT3 receptor antagonist, by buccal film delivery compared to IV injection for the prevention of chemotherapy-induced nausea and vomiting. Subjects receive a single dose of palonosetron prior to moderately emetogenic chemotherapy.
• On April 2023, Solasia Pharma K.K. announced a study of phase 3 clinical trials for Granisetron Hydrochloride Tablet and SP-01 (Granisetron Transdermal Delivery System). The purpose of this study is to assess the efficacy and safety of SP-01 in chemotherapy-induced nausea and vomiting (CINV) associated with the administration of moderately or highly emetogenic (ME or HE) multi-day chemotherapy which will provide scientific and reliable clinical data in the drug registration in China.
Chemotherapy Induced Nausea and Vomiting Overview
Chemotherapy Induced Nausea and Vomiting (CINV) are the side effects of cancer chemotherapy that can cause significant negative impacts on patients' quality of life and on their ability to tolerate and comply with therapy.
For further information, refer to the detailed Chemotherapy Induced Nausea and Vomiting Unmet Needs, click here for Chemotherapy Induced Nausea and Vomiting Ongoing Clinical Trial Analysis- https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chemotherapy Induced Nausea and Vomiting Emerging Drugs Profile
• APD403: Acacia Pharma
APD403 is based on the selective dopamine antagonist amisulpride. It is being developed as an intravenous injection for cancer patients to be administered immediately before they receive chemotherapy to prevent acute CINV, and as an oral tablet to prevent delayed CINV. The drug is currently in Phase II clinical studies for Chemotherapy-induced nausea and vomiting.
• CAM2047: Camurus
CAM2047 is along-acting subcutaneous granisetron depot for in development for the treatment of acute and delayed chemotherapy-induced nausea and vomiting. It is currently under Phase I stage of development for the treatment of Chemotherapy-induced nausea and vomiting.
Chemotherapy Induced Nausea and Vomiting Pipeline Therapeutics Assessment
There are approx. 15+ key companies which are developing the therapies for Chemotherapy Induced Nausea and Vomiting. The companies which have their Chemotherapy Induced Nausea and Vomiting drug candidates in the most advanced stage, i.e. phase II include, Acacia Pharma.
Request a sample and discover the recent advances in Chemotherapy Induced Nausea and Vomiting Ongoing Clinical Trial Analysis and Medications, Click here for more details @ Chemotherapy Induced Nausea and Vomiting Segmentation- https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chemotherapy Induced Nausea and Vomiting Drugs and Companies
• SP-01 (Granisetron Transdermal Delivery System): Solasia Pharma K.K.
• Granisetron Hydrochloride Tablet: Proswell Medical Corporation
• Palonosetron: Helsinn Healthcare SA
Chemotherapy Induced Nausea and Vomiting Therapeutics Assessment
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Some of the Companies in the Chemotherapy Induced Nausea and Vomiting Therapeutics Market include-
Acacia Pharma, Camurus, LP Pharmaceuticals, Skye Bioscience, TALLC Corporation, Starton Therapeutics, and others.
Dive deep into rich insights for drugs for Chemotherapy Induced Nausea and Vomiting Pipeline, click here @ Chemotherapy Induced Nausea and Vomiting Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Chemotherapy Induced Nausea and Vomiting Pipeline Report
• Coverage- Global
• Companies- Acacia Pharma, Camurus, LP Pharmaceuticals, Skye Bioscience, TALLC Corporation, Starton Therapeutics, and others.
• Therapies- SP-01 (Granisetron Transdermal Delivery System), Granisetron Hydrochloride Tablet, Pro-netupitant/Palonosetron, Netupitant/Palonosetron, Dexamethasone, Aprepitant, I.V. palonosetron, and others.
• Segmentation: Product Type, Molecule Type, Route of Administration
Got Queries? Find out the related information on Chemotherapy Induced Nausea and Vomiting Merger and acquisitions, Licensing Activities- https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Chemotherapy Induced Nausea and Vomiting: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Chemotherapy Induced Nausea and Vomiting - DelveInsight's Analytical Perspective
7. In-depth Commercial Assessment
8. Chemotherapy Induced Nausea and Vomiting Collaboration Deals
9. Late Stage Products (Phase III)
10. Drug name: Company name
11. Drug profiles in the detailed report…..
12. Mid Stage Products (Phase II)
13. APD403: Acacia Pharma
14. Drug profiles in the detailed report…..
15. Early Stage Products (Phase I)
16. CAM2047: Camurus
17. Drug profiles in the detailed report…..
18. Preclinical and Discovery Stage Products
19. TA-A002: TALLC Corporation
20. Drug profiles in the detailed report…..
21. Inactive Products
22. Chemotherapy Induced Nausea and Vomiting Key Companies
23. Chemotherapy Induced Nausea and Vomiting Key Products
24. Chemotherapy Induced Nausea and Vomiting- Unmet Needs
25. Chemotherapy Induced Nausea and Vomiting- Market Drivers and Barriers
26. Chemotherapy Induced Nausea and Vomiting- Future Perspectives and Conclusion
27. Chemotherapy Induced Nausea and Vomiting Analyst Views
28. Chemotherapy Induced Nausea and Vomiting Key Companies
29. Appendix
Published Important Links-
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://www.delveinsight.com/report-store/langerhans-cell-histiocytosis-market
https://www.delveinsight.com/report-store/shigellosis-market
https://www.delveinsight.com/report-store/overactive-bladder-market
https://www.delveinsight.com/report-store/somatotropin-deficiency-market
https://www.delveinsight.com/report-store/herpes-zoster-market
https://www.delveinsight.com/report-store/visual-cycle-modulation-vcm-market
https://www.delveinsight.com/report-store/cataract-surgery-complications-market
https://www.delveinsight.com/report-store/vulvovaginal-candidiasis-market
https://www.delveinsight.com/report-store/erosive-hand-osteoarthritis-market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market
https://www.delveinsight.com/report-store/herpetic-keratitis-market-size
https://www.delveinsight.com/report-store/hot-flashes-in-prostate-cancer-market
https://www.delveinsight.com/report-store/alcoholic-hepatitis-market
https://www.delveinsight.com/report-store/thrombotic-thrombocytopenic-purpura-market
https://www.delveinsight.com/report-store/renal-tubular-acidosis-market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
https://www.delveinsight.com/report-store/parkinsons-disease-psychosis-market
https://www.delveinsight.com/report-store/hyperphosphatemia-market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
https://www.delveinsight.com/report-store/cough-in-idiopathic-pulmonary-fibrosis-ipf-market
https://www.delveinsight.com/report-store/von-hippel-lindau-disease-market
https://www.delveinsight.com/report-store/venous-thromboembolism-market
https://www.delveinsight.com/report-store/urea-cycle-disorders-market
https://www.delveinsight.com/report-store/tendonitis-market
https://www.delveinsight.com/report-store/tendinopathy-market
https://www.delveinsight.com/report-store/systemic-lupus-erythematosus-market
https://www.delveinsight.com/report-store/synovial-sarcoma-market
https://www.delveinsight.com/report-store/smoking-cessation-market
https://www.delveinsight.com/report-store/myopia-progression-market
https://www.delveinsight.com/report-store/herpes-zoster-market
https://www.delveinsight.com/report-store/diabetic-nephropathy-market
https://www.delveinsight.com/report-store/geographic-atrophy-ga-market
https://www.delveinsight.com/report-store/carbapenem-resistant-enterobacteriaceae-infection-market
https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-market
https://www.delveinsight.com/report-store/alpha-thalassemia-market
https://www.delveinsight.com/report-store/biliary-atresia-market
https://www.delveinsight.com/report-store/celiac-disease-cd-market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
https://www.delveinsight.com/report-store/chronic-venous-ulceration-market
https://www.delveinsight.com/report-store/familial-adenomatous-polyposis-market
https://www.delveinsight.com/report-store/farbers-disease-market
https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
https://www.delveinsight.com/report-store/radiotherapy-induced-oral-mucositis-market
https://www.delveinsight.com/report-store/radiation-dermatitis-market
https://www.delveinsight.com/report-store/polymyalgia-rheumatica-market
https://www.delveinsight.com/report-store/peripheral-nerve-injuries-market
https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
https://www.delveinsight.com/report-store/type-1-diabetes-market
https://www.delveinsight.com/report-store/systemic-sclerosis-associated-interstitial-lung-disease-ssc-ild-market
https://www.delveinsight.com/report-store/relapsing-refractory-multiple-myeloma-market
https://www.delveinsight.com/report-store/radiation-induced-esophagitis-market-forecast
https://www.delveinsight.com/report-store/parainfluenza-virus-infection-market
https://www.delveinsight.com/report-store/ocular-hypertension-market
https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
About Us
DelveInsight s a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy Induced Nausea and Vomiting Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Domain | DelveInsight here
News-ID: 3281651 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Chemotherapy
Chemotherapy Devices Market - Innovation for Life: Chemotherapy Devices Driving …
Newark, New Castle, USA: The "Chemotherapy Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Chemotherapy Devices Market: https://www.growthplusreports.com/report/chemotherapy-devices-market/8623
This latest report researches the industry structure, sales, revenue,…
Chemotherapy Devices Market 2022 Will Boom With Advanced Chemotherapy Technologi …
New Research Study ""Chemotherapy Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight
The most recent Global Chemotherapy Devices Market report includes a high-level overview of the industry as well as in-depth analysis of key areas. The overview presented highlights the definition of products and services, as well as their associated applications, at the…
Cancer, chemotherapy and its treatment
Chemotherapy is one of the most commonly used cancer therapies. It employs the use of certain medications to destroy cancer cells or prevent them from spreading to other parts of the body. Chemotherapy may be prescribed alone or in combination with surgery or radiation therapy. Along with chemotherapy, you may also take newer types of cancer-fighting medications.
Chemotherapy can be taken as pills or as injections. You may visit a clinic…
Chemotherapy induced Nausea and Vomiting (CINV) TreatmentS Market Driven by Risi …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience…
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine
1.1 Overview
1.2 Nano Chemotherapeutics with Pharmaceutical Potential
Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations
2.1 Limitations of Conventional Chemotherapy
2.2 Nanotechnology in Cancer Targeting
2.2.1 Active Targeting
2.2.2 Passive Targeting
2.2.3 pH Dependent Drug Delivery Through Nanoparticles
Role…
Nano Chemotherapy Is Emerging As An Important Anti-Cancer Modality By Supplement …
“Global Nano Chemotherapy Market and Clinical Trials Outlook 2022” report highlights the current development in the in the field of nano chemotherapy. Report gives comprehensive insight on various clinical and non-clinical parameters associated with the expansion of global nano chemotherapeutics market. The clinical and pricing insight on chemotherapeutics nanoformulations of approved drugs helps to understand the current market scenario of the nano chemotherapeutics.
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Download Report:…
